Related references
Note: Only part of the references are listed.Bile Acid Signaling in Inflammatory Bowel Diseases
Stefano Fiorucci et al.
DIGESTIVE DISEASES AND SCIENCES (2021)
Berberine improves colitis by triggering AhR activation by microbial tryptophan catabolites
Wanghui Jing et al.
PHARMACOLOGICAL RESEARCH (2021)
Oral administration of Akkermansia muciniphila elevates systemic antiaging and anticancer metabolites
Claudia Grajeda-Iglesias et al.
Aging-US (2021)
Baitouweng Tang ameliorates DSS-induced ulcerative colitis through the regulation of the gut microbiota and bile acids via pathways involving FXR and TGR5
Yong-Li Hua et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Dysbiosis-Induced Secondary Bile Acid Deficiency Promotes Intestinal Inflammation
Sidhartha R. Sinha et al.
CELL HOST & MICROBE (2020)
Fucose Ameliorate Intestinal Inflammation Through Modulating the Crosstalk Between Bile Acids and Gut Microbiota in a Chronic Colitis Murine Model
Jun Ke et al.
INFLAMMATORY BOWEL DISEASES (2020)
Gut microbiota-derived metabolites as key actors in inflammatory bowel disease
Aonghus Lavelle et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
Bile Acids Signal via TGR5 to Activate Intestinal Stem Cells and Epithelial Regeneration
Giovanni Sorrentino et al.
GASTROENTEROLOGY (2020)
A purified membrane protein from Akkermansia muciniphila or the pasteurised bacterium blunts colitis associated tumourigenesis by modulation of CD8+ T cells in mice
Lijuan Wang et al.
GUT (2020)
The Bacterium Akkermansia muciniphila: A Sentinel for Gut Permeability and Its Relevance to HIV-Related Inflammation
Jing Ouyang et al.
FRONTIERS IN IMMUNOLOGY (2020)
Review article: bugs, inflammation and mood-a microbiota-based approach to psychiatric symptoms in inflammatory bowel diseases
Anne K. Thomann et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)
Evodiamine has therapeutic efficacy in ulcerative colitis by increasing Lactobacillus acidophilus levels and acetate production
Meng-Xia Wang et al.
PHARMACOLOGICAL RESEARCH (2020)
Pathophysiology of Inflammatory Bowel Diseases
John T. Chang
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Paeoniflorin modulates gut microbial production of indole-3-lactate and epithelial autophagy to alleviate colitis in mice
Qilin Fan et al.
PHYTOMEDICINE (2020)
The Effect of Dihydromyricetin, a Natural Flavonoid, on Morphine-induced Conditioned Place Preference and Physical Dependence in Mice
Leila Etemad et al.
DRUG RESEARCH (2020)
The secondary bile acids, ursodeoxycholic acid and lithocholic acid, protect against intestinal inflammation by inhibition of epithelial apoptosis
Natalia K. Lajczak-McGinley et al.
PHYSIOLOGICAL REPORTS (2020)
Dihydromyricetin alleviates acetaminophen-induced liver injury via the regulation of transformation, lipid homeostasis, cell death and regeneration
Sijing Dong et al.
LIFE SCIENCES (2019)
Chenodeoxycholic Acid (CDCA) Protects against the Lipopolysaccharide-Induced Impairment of the Intestinal Epithelial Barrier Function via the FXR-MLCK Pathway
Min Song et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2019)
Preparation of a nanoscale dihydromyricetin-phospholipid complex to improve the bioavailability: in vitro and in vivo evaluations
Xinyuan Zhao et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
Gut microbiome structure and metabolic activity in inflammatory bowel disease
Eric A. Franzosa et al.
NATURE MICROBIOLOGY (2019)
Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis
Wei Jia et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
The gut microbiota, bile acids and their correlation in primary sclerosing cholangitis associated with inflammatory bowel disease
J. Torres et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2018)
Interactions of Dihydromyricetin, a Flavonoid from Vine Tea (Ampelopsis grossedentata) with Gut Microbiota
Li Fan et al.
JOURNAL OF FOOD SCIENCE (2018)
Berberine Upregulates P-Glycoprotein in Human Caco-2 Cells and in an Experimental Model of Colitis in the Rat via Activation of Nrf2-Dependent Mechanisms
Wanghui Jing et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2018)
Bile Acid G Protein-Coupled Membrane Receptor TGR5 Modulates Aquaporin 2-Mediated Water Homeostasis
Suchun Li et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders
Diego Curro et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Modified low-salt CTAB extraction of high-quality DNA from contaminant-rich tissues
Jean-Rene Arseneau et al.
MOLECULAR ECOLOGY RESOURCES (2017)
Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies
Siew C. Ng et al.
LANCET (2017)
Mori Cortex regulates P-glycoprotein in Caco-2 cells and colons from rats with experimental colitis via direct and gut microbiota-mediated mechanisms
Wanghui Jing et al.
RSC ADVANCES (2017)
Pili-like proteins of Akkermansia muciniphila modulate host immune responses and gut barrier function
Noora Ottman et al.
PLOS ONE (2017)
Ursodeoxycholic acid and lithocholic acid exert anti-inflammatory actions in the colon
Joseph B. J. Ward et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2017)
Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism
Annika Wahlstrom et al.
CELL METABOLISM (2016)
A Disease-Associated Microbial and Metabolomics State in Relatives of Pediatric Inflammatory Bowel Disease Patients
Jonathan P. Jacobs et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2016)
The global burden of IBD: from 2015 to 2025
Gilaad G. Kaplan
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2015)
Effect of chenodeoxycholic acid and sodium hydrogen sulfide in dinitro benzene sulfonic acid (DNBS) - Induced ulcerative colitis in rats
Nidhi Goyal et al.
PHARMACOLOGICAL REPORTS (2015)
Immune System Stimulation by Probiotic Microorganisms
Rabia Ashraf et al.
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2014)
Secondary bile acids: an underrecognized cause of colon cancer
Hana Ajouz et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2014)
PPARα-UGT axis activation represses intestinal FXR-FGF15 feedback signalling and exacerbates experimental colitis
Xueyan Zhou et al.
NATURE COMMUNICATIONS (2014)
The Receptor TGR5 Mediates the Prokinetic Actions of Intestinal Bile Acids and Is Required for Normal Defecation in Mice
Farzad Alemi et al.
GASTROENTEROLOGY (2013)
Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases
Henri Duboc et al.
GUT (2013)
Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease
Raffaella M. Gadaleta et al.
GUT (2011)
The Bile Acid Receptor GPBAR-1 (TGR5) Modulates Integrity of Intestinal Barrier and Immune Response to Experimental Colitis
Sabrina Cipriani et al.
PLOS ONE (2011)
Bile acids: regulation of synthesis
John Y. L. Chiang
JOURNAL OF LIPID RESEARCH (2009)